121 related articles for article (PubMed ID: 7075036)
1. Middle molecules in patients with pre-dialysis chronic renal failure: a comparative clearance study.
Schindhelm K; Lustenberger N; Nordmeyer C; Farrell P; Stolte H
Clin Nephrol; 1982 Apr; 17(4):200-5. PubMed ID: 7075036
[TBL] [Abstract][Full Text] [Related]
2. Renal handling of middle molecules in uremic patients and in the isolated rat kidney.
Lustenberger N; Schindhelm K; Nordmeyer C; Schurek HJ; Stolte H
Artif Organs; 1981; 4 Suppl():110-4. PubMed ID: 7295076
[TBL] [Abstract][Full Text] [Related]
3. Contribution of tubular anion and cation secretion to residual renal function in chronic dialysis patients.
van Olden RW; van Acker BA; Koomen GC; Krediet RT; Arisz L
Clin Nephrol; 1998 Mar; 49(3):167-72. PubMed ID: 9543598
[TBL] [Abstract][Full Text] [Related]
4. Glomerular filtration rate measurement in cirrhotic patients with renal failure.
Roy L; Legault L; Pomier-Layrargues G
Clin Nephrol; 1998 Dec; 50(6):342-6. PubMed ID: 9877106
[TBL] [Abstract][Full Text] [Related]
5. Renal handling of uremic middle molecules. a study with the isolated perfused rat kidney.
Schindhelm K; Schlatter E; Schurek HJ; Stolte H
Nephron; 1982; 30(2):166-72. PubMed ID: 7099324
[TBL] [Abstract][Full Text] [Related]
6. Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis.
Korevaar JC; Jansen MA; Dekker FW; Boeschoten EW; Krediet RT
Adv Perit Dial; 1999; 15():132-7. PubMed ID: 10682088
[TBL] [Abstract][Full Text] [Related]
7. The effect of hemodialysis on endogenous middle molecules in uremic patients.
Asaba H; Fürst P; Oulés R; Yahiel V; Zimmerman L; Bergström J
Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
[TBL] [Abstract][Full Text] [Related]
9. Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study.
Dittrich E; Puttinger H; Schillinger M; Lang I; Stefenelli T; Hörl WH; Vychytil A
Nephrol Dial Transplant; 2006 May; 21(5):1334-9. PubMed ID: 16046499
[TBL] [Abstract][Full Text] [Related]
10. [Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency].
Hottelart C; el Esper N; Achard JM; Pruna A; Fournier A
Nephrologie; 1999; 20(1):41-4. PubMed ID: 10081035
[TBL] [Abstract][Full Text] [Related]
11. Accumulation and excretion of middle molecules.
Asaba H
Clin Nephrol; 1983 Mar; 19(3):116-23. PubMed ID: 6839560
[TBL] [Abstract][Full Text] [Related]
12. Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low.
Almond A; Siddiqui S; Robertson S; Norrie J; Isles C
QJM; 2008 Aug; 101(8):619-24. PubMed ID: 18540009
[TBL] [Abstract][Full Text] [Related]
13. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease.
Kuan Y; Hossain M; Surman J; El Nahas AM; Haylor J
Nephrol Dial Transplant; 2005 Nov; 20(11):2394-401. PubMed ID: 16115853
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
17. Middle molecules in uremic serum, urine and dialysis fluid.
Migone L; Dall'taglio P; Buzio C
Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803
[TBL] [Abstract][Full Text] [Related]
18. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
Iseki K; Kinjo K; Iseki C; Takishita S
Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease.
Teichert J; Tuemmers T; Achenbach H; Preiss C; Hermann R; Ruus P; Preiss R
J Clin Pharmacol; 2005 Mar; 45(3):313-28. PubMed ID: 15703366
[TBL] [Abstract][Full Text] [Related]
20. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis.
Caregaro L; Menon F; Angeli P; Amodio P; Merkel C; Bortoluzzi A; Alberino F; Gatta A
Arch Intern Med; 1994 Jan; 154(2):201-5. PubMed ID: 8285815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
